CD25 monoclonal antibody–containing GVHD prophylaxis
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD25 monoclonal antibody–containing GVHD prophylaxis, covering 2024-06-28 to 2024-06-28. Get the full timeline:
Most recent: Clinical Trial Update: Effectiveness and Safety of a Single-Center Clinical Study on a CD25 Monoclonal Antibody-Containing GVHD Prophylaxis Scheme to Reduce the Incidence of Severe Acute GVHD After Umbilical Cord Blood Transplantation for Malignant Hematologic Diseases [Phase 2]